Befloxatone
Names | |
---|---|
IUPAC name
(R)-5-(methoxymethyl)-3-(4-((R)-4,4,4-trifluoro-3-hydroxybutoxy)phenyl)-oxazolidin-2-one | |
Identifiers | |
134564-82-2 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL416578 |
ChemSpider | 54811 |
6637 | |
KEGG | D02563 |
PubChem | 60824 |
UNII | 4H75PAD8M3 |
| |
| |
Properties | |
C15H18F3NO5 | |
Molar mass | 349.30233 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Befloxatone (MD-370,503) is a reversible inhibitor of monoamine oxidase A.[1][2]
References
- ↑ Emilien, G (March 1999). "Befloxatone (Synthelabo)". IDrugs. 2 (3): 247–253. PMID 16160936.
- ↑ Warot, Dominique; Berlin, Ivan; Patat, Alain; Durrieu, Geneviève; Zieleniuk, Isabelle; Puech, Alain J (October 1996). "Effects of Befloxatone, a Reversible Selective Monoamine Oxidase-A Inhibitor, on Psychomotor Function and Memory in Healthy Subjects". The Journal of Clinical Pharmacology. 1552-4604. Blackwell Publishing Ltd. 36 (10): 942–950. doi:10.1002/j.1552-4604.1996.tb04762.x. PMID 8930782.
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.